At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
IBB iShares Biotechnology ETF
Trading 08-05 13:28:26 EDT
191.84
+1.69
+0.89%
High194.13Low191.00Vol761.96K
Open191.88D1 Closing190.15Amplitude1.65%
Mkt Cap9.50BTradable Cap9.50BTotal Shares49.50M
T/O146.63MT/O Rate1.54%Tradable Shares49.50M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Staar Surgical (STAA) and Elanco Animal Health (ELAN)
TIPRANKS  ·  58 minutes ago
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Staar Surgical (STAA) and Elanco Animal Health (ELAN)
Gilead Sciences Inc Stock (GILD) Moved Down by 3.96% on Aug 5: A Full Analysis
TradingKey  ·  00:15
Gilead Sciences Inc Stock (GILD) Moved Down by 3.96% on Aug 5: A Full Analysis
Gilead Sciences (GILD) Faces Fresh HIV Access Criticism From AIDS Healthcare Foundation
Simply Wall St.  ·  08-05 23:23
Gilead Sciences (GILD) Faces Fresh HIV Access Criticism From AIDS Healthcare Foundation
Amgen is Maintained at Equal-Weight by Wells Fargo
Dow Jones  ·  08-05 23:03
Amgen is Maintained at Equal-Weight by Wells Fargo
NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-05
Reuters  ·  08-05 23:01
NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-05
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Ultragenyx Pharmaceutical (RARE) and Beam Therapeutics (BEAM)
TIPRANKS  ·  08-05 22:40
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Ultragenyx Pharmaceutical (RARE) and Beam Therapeutics (BEAM)
Amgen Jolts to Record-High After Hiking FY Forecasts, Q2 Results Beat
Reuters  ·  08-05 22:40
Amgen Jolts to Record-High After Hiking FY Forecasts, Q2 Results Beat
Amgen Shares Hit Record High; Last up 6.3% at $414.61
THOMSON REUTERS  ·  08-05 22:09
Amgen Shares Hit Record High; Last up 6.3% at $414.61
Amgen Shares up 5% After Q2 Results Beat Estimates; FY Profit Forecast Raise
THOMSON REUTERS  ·  08-05 21:55
Amgen Shares up 5% After Q2 Results Beat Estimates; FY Profit Forecast Raise
Dow's 500-Point Rally Led by Gains in Amgen, Nvidia Corp. Shares
Dow Jones  ·  08-05 21:45
Dow's 500-Point Rally Led by Gains in Amgen, Nvidia Corp. Shares
Amgen Inc : Canaccord Genuity Raises Target Price to $384 from $366
THOMSON REUTERS  ·  08-05 21:14
Amgen Inc : Canaccord Genuity Raises Target Price to $384 from $366
Sector Update: Healthcare
MT Newswires Live  ·  08-05 21:01
Sector Update: Healthcare
Immuneering Expects Cash Runway to Fund Operations into 2029
Reuters  ·  08-05 19:40
Immuneering Expects Cash Runway to Fund Operations into 2029
Analysts Offer Insights on Healthcare Companies: Exagen (XGN), Amgen (AMGN) and Arvinas Holding Company (ARVN)
TIPRANKS  ·  08-05 19:40
Analysts Offer Insights on Healthcare Companies: Exagen (XGN), Amgen (AMGN) and Arvinas Holding Company (ARVN)
Kymera Therapeutics Q2 Collaboration Revenue More than Doubles, Beats Estimates
Reuters  ·  08-05 19:15
Kymera Therapeutics Q2 Collaboration Revenue More than Doubles, Beats Estimates
Gilead : Leerink Partners Raises Target Price to $130 from $126
THOMSON REUTERS  ·  08-05 18:16
Gilead : Leerink Partners Raises Target Price to $130 from $126
Amgen Inc : Scotiabank Raises Target Price to $450 from $385
THOMSON REUTERS  ·  08-05 17:20
Amgen Inc : Scotiabank Raises Target Price to $450 from $385
Gilead Sciences (GILD) Gets a Buy from Wells Fargo
TIPRANKS  ·  08-05 17:16
Gilead Sciences (GILD) Gets a Buy from Wells Fargo
Gilead Buy Rating Reaffirmed on Strong HIV-Driven Growth and Raised Revenue Outlook; $170 Price Target Maintained
TIPRANKS  ·  08-05 16:56
Gilead Buy Rating Reaffirmed on Strong HIV-Driven Growth and Raised Revenue Outlook; $170 Price Target Maintained
Street View: Gilead's HIV Strength Outshines Long-Term Competitive Worries
Reuters  ·  08-05 16:47
Street View: Gilead's HIV Strength Outshines Long-Term Competitive Worries

Introduction

Company Name.
iShares Biotechnology ETF
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Issue price:
--